Search
for
Sort by
Research 31–60 of 221
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Adverse Drug Reactions in HIV/AIDS Patients on Highly Active Antiretro Viral Therapy: A Review of Prevalence
- Diabetes and Skin — A Review
- Hutchinson-Gilford progeria syndrome: Report of 2 cases and a novel LMNA mutation of HGPS in China
- Skin disorders in diabetes mellitus
- Treatment of acne with intermittent isotretinoin, cohort study
- Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome
- Parry-Romberg Syndrome Vasculopathy and Its Treatment With Botulinum Toxin
- Are Pediatric GLP ‐1 Receptor Agonist Cutaneous Adverse Events Being Overlooked? Emerging Age‐Specific Patterns and Their Implications for Dermatologists
- Berardinelli–Seip syndrome
- Animals in Dermatology
- Radiesse
- Adipocytes in Skin Health and Disease
- Skin and metabolic syndrome: A review of the possible associations
- Journal Watch
- New Insight for Enhanced Topical Targeting of Caffeine for Effective Cellulite Treatment: In Vitro Characterization, Permeation Studies, and Histological Evaluation in Rats
- A Clinical Approach to Severe Insulin Resistance
- E.L.F. sqare waves: a new therapy for androgenetic alopecia?
- Progeroide Syndrome
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- Acanthosis nigricans, insulin resistance and cutaneous virilism
- <i>WNT10A</i> , dermatology and dentistry
- Hypersensitivity Reactions to Anticoagulant Drugs
- Treatment of severe alopecia areata with baricitinib
- Kojyl Cinnamate Ester Derivatives Increase Adiponectin Expression and Stimulate Adiponectin-Induced Hair Growth Factors in Human Dermal Papilla Cells
- Nephrogenic systemic fibrosis: Report of two cases
- Atrophying scamous papulous dermatitis (Degos disease): Nine years of follow-up
- A preliminary result of adipose derived stem cell treatment for female pattern hair loss
- The Role of Adipocytes in Tissue Regeneration and Stem Cell Niches
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III